Insilico Medicine & ASKA Partner to Advance AI-Driven Treatments for Gynecological Diseases March 25, 2026 by Mathieu Maurice Insilico Medicine, a clinical-stage biotechnology company specializing in generative artificial intelligence (AI) for drug discovery and development, has announced a strategic research partnership with ASKA Pharmaceutical Co., Ltd. (“ASKA”), a …